BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 6702732)

  • 1. Pathologic hyperfibrinolysis associated with amyloidosis: clinical response to epsilon amino caproic acid.
    Chang JC; Kane KK
    Am J Clin Pathol; 1984 Mar; 81(3):382-7. PubMed ID: 6702732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrinolysis and acquired alpha-2 plasmin inhibitor deficiency in amyloidosis.
    Meyer K; Williams EC
    Am J Med; 1985 Sep; 79(3):394-6. PubMed ID: 4036990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated urokinase-type plasminogen activator level and bleeding in amyloidosis: case report and literature review.
    Sane DC; Pizzo SV; Greenberg CS
    Am J Hematol; 1989 May; 31(1):53-7. PubMed ID: 2495717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Massive bleeding with fibrinolysis: management with heparin and epsilon aminocaproic acid.
    Bergin JJ; Crosby WH; Jahnke EJ
    Mil Med; 1966 Apr; 131(4):340-4. PubMed ID: 4955920
    [No Abstract]   [Full Text] [Related]  

  • 5. [EXISTENCE OF CHANGES IN HEMOSTASIS WITH DECREASED FIBRINOLYSIS. BASIS FOR THE HEMOSTATIC TREATMENT WITH EPSILON AMINOCAPROIC ACID IN NON FIBRINOLYTIC HEMORRHAGIC DIATHESIS].
    CASTILLO R; SERRANO J; CARALPS A; VINAS M
    Med Clin (Barc); 1963 Oct; 41():302-6. PubMed ID: 14125259
    [No Abstract]   [Full Text] [Related]  

  • 6. Primary amyloidosis and myelomatosis associated with excessive fibrinolytic acitivty.
    Millard LG; Rowell NR
    Br J Dermatol; 1976 May; 94(5):569-71. PubMed ID: 1268067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epsilon-aminocaproic acid for treatment of fibrinolysis during liver transplantation.
    Kang Y; Lewis JH; Navalgund A; Russell MW; Bontempo FA; Niren LS; Starzl TE
    Anesthesiology; 1987 Jun; 66(6):766-73. PubMed ID: 3296855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Control of bleeding after renal biopsy with epsilon-amino-caproic acid.
    Savdie E; Mahony JF; Storey BG
    Br J Urol; 1978 Feb; 50(1):8-11. PubMed ID: 630206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [FIBRINOLYSIS; APPLICATION IN THE CLINIC (EPSILON-AMINOCAPROIC ACID)].
    MOERS AM; BOSMAN GA
    Folia Med Neerl; 1964 Dec; 7():175-8. PubMed ID: 14265805
    [No Abstract]   [Full Text] [Related]  

  • 10. Amyloidosis with and unusual bleeding diathesis; observations on the use of epsilon amino caproic acid.
    REDLEAF PD; DAVIS RB; KUCINSKI C; HOILUND L; GANS H
    Ann Intern Med; 1963 Feb; 58():347-54. PubMed ID: 13973518
    [No Abstract]   [Full Text] [Related]  

  • 11. The use of frusemide and epsilon-amino-caproic-acid in transurethral prostatectomy. a review after 7 years.
    Smart CJ
    Br J Urol; 1982 Aug; 54(4):437. PubMed ID: 7116117
    [No Abstract]   [Full Text] [Related]  

  • 12. Successful treatment of skeletal hemangioma and Kasabach-Merritt syndrome with aminocaproic acid. Is fibrinolysis "defensive"?
    Neidhart JA; Roach RW
    Am J Med; 1982 Sep; 73(3):434-8. PubMed ID: 7124770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased fibrinolysis and amyloidosis.
    Liebman H; Chinowsky M; Valdin J; Kenoyer G; Feinstein D
    Arch Intern Med; 1983 Apr; 143(4):678-82. PubMed ID: 6340622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FIBRINOLYTIC BLEEDING AND ITS MANAGEMENT.
    SHERRY S; FLETCHER AP; ALKJAERSIG N
    Ann N Y Acad Sci; 1964 Jul; 115():481-92. PubMed ID: 14192857
    [No Abstract]   [Full Text] [Related]  

  • 15. [EPSILON-AMINO-CAPROIC ACID IN THE TREATMENT OF HEMORRHAGIC DISEASE OF THE NEWBORN].
    MARZETTI L
    Quad Clin Ostet Ginecol; 1964 Nov; 19():721-5. PubMed ID: 14279386
    [No Abstract]   [Full Text] [Related]  

  • 16. epsilon-Amino-caproic acid in the management of acute promyelocytic leukaemia.
    Keane TJ; Gorman AM; O'Connell LG; Fennelly JJ
    Acta Haematol; 1976; 56(4):202-4. PubMed ID: 826076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CIRCULATING FIBRINOLYTIC ACTIVATOR AND HEMORRHAGIC DIATHESIS.
    ENDE N; AUDITORE JV
    Ann Surg; 1963 Jul; 158(1):117-25. PubMed ID: 14042622
    [No Abstract]   [Full Text] [Related]  

  • 18. [PRELIMINARY OBSERVATIONS ON THE THERAPEUTIC EFFICACY OF EPSILON-AMINO-CAPROIC ACID IN HEMORRHAGIC SYNDROMES DUE TO BLOOD PLATELET DEFECTS].
    MANDELLI F; DERIU L; OMODEI-ZORINI C
    Policlinico Prat; 1964 Sep; 71():1454-7. PubMed ID: 14204185
    [No Abstract]   [Full Text] [Related]  

  • 19. Thrombogenic properties of epsilon amino caproic acid.
    Gans H
    Ann Surg; 1966 Feb; 163(2):175-8. PubMed ID: 5906607
    [No Abstract]   [Full Text] [Related]  

  • 20. EXPERIMENTAL VENOUS THROMBOSIS IN RATS. INCREASED FORMATION DURING INHIBITION OF THE FIBRINOLYTIC SYSTEM WITH EPSILON AMINO CAPROIC ACID.
    NORDOEY A
    Thromb Diath Haemorrh; 1963 Jul; 143():427-35. PubMed ID: 14081264
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.